Search

Search Constraints

You searched for: Author/Creator Gamis, Alan S.

Search Results

21. Mixed‐phenotype acute leukemia: A cohort and consensus research strategy from the Children's Oncology Group Acute Leukemia of Ambiguous Lineage Task Force. Issue 3 (29th October 2019)

22. MYOD1 as a prognostic indicator in rhabdomyosarcoma. Issue 9 (29th April 2021)

23. Outcome of pediatric patients with acute myeloid leukemia (AML) and −5/5q− abnormalities from five pediatric AML treatment protocols: A report from the Children's Oncology Group. Issue 12 (30th August 2013)

24. Outcomes of intensification of induction chemotherapy for children with high‐risk acute myeloid leukemia: A report from the Children's Oncology Group. Issue 12 (1st October 2021)

25. Pathologic, cytogenetic, and molecular features of acute myeloid leukemia with megakaryocytic differentiation: A report from the Children's Oncology Group. Issue 5 (15th February 2023)

26. Phase I/II trial of clofarabine and cytarabine in children with relapsed/refractory acute lymphoblastic leukemia (AAML0523): A report from the Children's Oncology Group1. Issue 7 (17th January 2013)

27. Risk Markers for Significant Bleeding and Thrombosis in Pediatric Acute Promyelocytic Leukemia; Report From the Children's Oncology Group Study AAML0631. Issue 1 (January 2019)

28. Significance of expression of ITGA5 and its splice variants in acute myeloid leukemia: A report from the children's oncology group. Issue 8 (20th June 2013)

29. The prognostic effect of high diagnostic WT1 gene expression in pediatric AML depends on WT1 SNP rs16754 status: Report from the Children's Oncology Group. Issue 1 (16th August 2013)